Comparing 18 vendors in Molecular Diagnostics across 0 criteria.
ContendersMarket Leaders 
Emerging CompaniesInnovators 
Qiagen
bioMérieux
Biocartis
BD
Roche
Thermo Fisher
Hologic
Danaher
DiaSorin
Siemens Healthineers
Abbott
Illumina
Agilent
Grifols
mdxhealth
Myriad Genetics
Revvity
QuidelOrtho
Access Research To
- Expand Total Addressable Market
- Formulate Go To Market Plans
- Build Competitive Right to Win
- Identify Top Customers to Grow
Error!!!
Oops! Something went wrong. Please try again later.
POWERED BY MARKETSANDMARKETS
Sep 21, 2023
360 Quadrants releases a list of "Top 18 Molecular Diagnostics Companies, worldwide 2023" in partnership with MarketsandMarkets. The report recognizes standouts in Molecular Diagnostics, ranging from mid-sized enterprises to Fortune 500 companies. The vendor evaluation was conducted on over two hundred companies of which the top 18 were categorized and recognized as the new economic quadrant leaders.
Key trends highlighted in 360 Quadrants:
- The Molecular Diagnostics market is valued at an estimated USD 16,669.5 million in 2023 and is projected to reach USD 28631.5 million by 2028 at a CAGR 11.4% during the forecast period. Market growth is largely driven by the increasing prevalence of infectious diseases and cancer and the growing funding for R&D in molecular diagnostics.
- North America accounted for the largest share in the molecular diagnostics market. The large share of North America in this market can be attributed to the increasing prevalence of infectious diseases and cancer, increasing healthcare spending, the highly developed healthcare system in the US and Canada.
- The region has a robust infrastructure for R&D, which has led to the rapid adoption of innovative diagnostic techniques and platforms. Also, North America have several major companies in the molecular diagnostics sector.
- The molecular diagnostics market has experienced significant growth and advancements in recent years. Molecular diagnostics refers to the use of molecular biology techniques to detect and analyze genetic variations, gene expression patterns, and other biomarkers associated with diseases.
- The market for molecular diagnostics has been driven by several factors, including the increasing prevalence of infectious diseases, the growing demand for personalized medicine, and the need for more accurate and rapid diagnostic methods.
- Additionally, advancements in technology, such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and microarray techniques, have expanded the capabilities of molecular diagnostics, enabling the detection of a wide range of genetic and infectious diseases.
- The market for molecular diagnostics is highly competitive, with numerous companies offering a wide range of tests and platforms. Key players in the industry include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Thermo Fisher Scientific and Qiagen. These companies invest heavily in research and development to innovate and launch new products, aiming to improve sensitivity, specificity, and turnaround time of molecular diagnostic tests.
The Full List
The Full List
| Company | Headquarters | Year Founded | Holding Type |
|---|---|---|---|
| Abbott | Chicago, USA | 1888 | Public |
| Agilent | Santa Clara, USA | 1999 | Public |
| BD | Franklin Lakes, USA | 1897 | Public |
| Biocartis | Mechelen, Belgium | 2007 | Private |
| Danaher | Washington, D.C., USA | 1984 | Public |
| DiaSorin | Vercelli, Italy | 1968 | Private |
| Grifols | Barcelona, Spain | 1909 | Public |
| Hologic | Marlborough, USA | 1985 | Public |
| Illumina | San Diego, USA | 1998 | Public |
| Myriad Genetics | Salt Lake City , USA | 1991 | Public |
| Qiagen | Hilden, Germany | 1984 | Public |
| QuidelOrtho | San Diego, USA | 1979 | Public |
| Revvity | Waltham, USA | 2023 | Public |
| Roche | Basel, Switzerland | 1896 | Private |
| Siemens Healthineers | Erlangen, Germany | 1847 | Public |
| Thermo Fisher | Waltham, USA | 1956 | Private |
| bioMérieux | AR, France | 1963 | Public |
| mdxhealth | Herstal, Belgium | 2003 | Public |
Frequently Asked Questions (FAQs)
The method of diagnosing an illness by studying molecules in a tissue or fluid such as proteins, DNA, and RNA.
A molecular test for a common inherited hereditary cancer can be performed by doctors. In the case of breast cancer, for example, they can look for specific hereditary abnormalities in the BRCA1 and BRCA2 genes that may increase the patient's chance of developing breast and ovarian cancer.
The Molecular Diagnostics Laboratory oversees developing and executing molecular diagnostic assays for nucleic acid targets present in a range of medical contexts.
Molecular diagnostics are increasingly being used to guide patient management, from diagnosis to treatment, in sectors such as cancer, infectious disease, and congenital anomalies.
These technologies are broadly classified as polymerase chain reaction (PCR), hybridization, and next-generation sequencing (NGS). Currently, the FDA has approved a large number of PCR and hybridization assays as in vitro diagnostics.
Molecular PCR testing. A polymerase chain reaction (PCR) test is a specific type of molecular test used to amplify specific sections of DNA for a wide range of purposes, such as:
Other NAATs.
Rapid molecular testing.
Commercial at-home tests.
Antibiotic susceptibility testing.
Genetic tests.
In the future, molecular diagnostics may be able to guide clinicians to the best medicine for each patient, regardless of ailment. Despite the enormous promise of molecular diagnostics, laboratories that use it will undoubtedly encounter problems that are common to every new technology.
A single light-blue citrate tube is used to collect 3 mL of whole blood. The tubes are promptly sealed in plastic bags (at room temperature) and shipped to the Molecular Diagnostics Unit.
PCR is a chemical reaction that exponentially amplifies the targeted nucleic acid to detectable amounts, catalyzed by fast temperature cycling. The amount of genetic material in the beginning sample is doubled after one cycle of PCR. Performing numerous PCR cycles generates millions to billions of copies.
Protein methods, immunostaining methods, and nucleic acid methods are the most often utilized molecular biology methods.
Research Methodology
If your company is recognised in this Quadrant, Leverage this ranking using our Marketing Kit.
